DE59409179D1 - Chinolin-Verbindungen als Leukotriene Antagonisten - Google Patents

Chinolin-Verbindungen als Leukotriene Antagonisten

Info

Publication number
DE59409179D1
DE59409179D1 DE59409179T DE59409179T DE59409179D1 DE 59409179 D1 DE59409179 D1 DE 59409179D1 DE 59409179 T DE59409179 T DE 59409179T DE 59409179 T DE59409179 T DE 59409179T DE 59409179 D1 DE59409179 D1 DE 59409179D1
Authority
DE
Germany
Prior art keywords
quinoline compounds
antagonists
leukotrienes
leukotrienes antagonists
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59409179T
Other languages
German (de)
English (en)
Inventor
Sprecher Dr Von
Dr Beck
Dr Gerspacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Erfindungen Verwaltungs GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfindungen Verwaltungs GmbH, Novartis AG filed Critical Novartis Erfindungen Verwaltungs GmbH
Application granted granted Critical
Publication of DE59409179D1 publication Critical patent/DE59409179D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE59409179T 1993-09-10 1994-09-01 Chinolin-Verbindungen als Leukotriene Antagonisten Expired - Lifetime DE59409179D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810645 1993-09-10

Publications (1)

Publication Number Publication Date
DE59409179D1 true DE59409179D1 (de) 2000-04-13

Family

ID=8215029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59409179T Expired - Lifetime DE59409179D1 (de) 1993-09-10 1994-09-01 Chinolin-Verbindungen als Leukotriene Antagonisten

Country Status (20)

Country Link
US (1) US5508408A (enExample)
JP (1) JP3652721B2 (enExample)
KR (1) KR950008483A (enExample)
CN (1) CN1054845C (enExample)
AT (1) ATE190307T1 (enExample)
AU (1) AU683481B2 (enExample)
CA (1) CA2131644C (enExample)
CZ (1) CZ284006B6 (enExample)
DE (1) DE59409179D1 (enExample)
ES (1) ES2144501T3 (enExample)
FI (1) FI944120A7 (enExample)
HU (1) HUT70556A (enExample)
IL (1) IL110864A0 (enExample)
NO (1) NO301639B1 (enExample)
NZ (1) NZ264420A (enExample)
PH (1) PH31094A (enExample)
PT (1) PT643045E (enExample)
SK (1) SK107394A3 (enExample)
TW (1) TW249802B (enExample)
ZA (1) ZA946957B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ515087A (en) 1999-04-28 2003-11-28 Aventis Pharma Gmbh Tri-aryl acid derivatives as PPAR receptor ligands
IT1320162B1 (it) 2000-02-09 2003-11-18 Rotta Research Lab Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico.
US6531494B1 (en) * 2001-08-29 2003-03-11 Pharmacia Corporation Gem-substituted αvβ3 antagonists
US7056917B2 (en) * 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109009A (en) * 1985-03-08 1992-04-28 Leo Pharmaceutical Products Ltd. Quinoline and pyridine compounds and inhibition of 5-lipoxygenases therewith
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4962203A (en) * 1985-06-18 1990-10-09 Merck Frost Canada, Inc. 2-substituted quinolines useful as leukotriene antagonists
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
EP0219307A3 (en) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. 2-substituted quinolines
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
JPS62145049A (ja) * 1985-12-18 1987-06-29 Mitsubishi Chem Ind Ltd アミノスチリル化合物及びそれを有効成分とするロイコトリエンきつ抗剤
JPS63258854A (ja) * 1987-04-16 1988-10-26 Mitsubishi Kasei Corp カルボキシスチレン誘導体およびそれを有効成分とする薬剤
ES2052825T3 (es) * 1988-07-15 1994-07-16 Hoffmann La Roche Derivados de cicloalquiltiazol.
JPH02275857A (ja) * 1989-01-13 1990-11-09 Yoshitomi Pharmaceut Ind Ltd ピリジン誘導体
CN1078151A (zh) * 1993-01-01 1993-11-10 周礼伯 天然药物成分的蚕药
CN1050999C (zh) * 1993-02-16 2000-04-05 胡祖良 抗病毒性蚕病的蚕药

Also Published As

Publication number Publication date
TW249802B (enExample) 1995-06-21
ATE190307T1 (de) 2000-03-15
CA2131644C (en) 2007-04-24
US5508408A (en) 1996-04-16
AU683481B2 (en) 1997-11-13
CZ218794A3 (en) 1995-03-15
CN1054845C (zh) 2000-07-26
CN1105991A (zh) 1995-08-02
NO943336L (no) 1995-03-13
SK107394A3 (en) 1995-05-10
NZ264420A (en) 1996-06-25
IL110864A0 (en) 1994-11-28
CZ284006B6 (cs) 1998-07-15
ZA946957B (en) 1995-04-18
AU7161794A (en) 1995-03-23
CA2131644A1 (en) 1995-03-11
HUT70556A (en) 1995-10-30
JP3652721B2 (ja) 2005-05-25
HU9402585D0 (en) 1994-11-28
NO301639B1 (no) 1997-11-24
FI944120A7 (fi) 1995-03-11
KR950008483A (ko) 1995-04-17
PH31094A (en) 1998-02-05
JPH07179426A (ja) 1995-07-18
FI944120A0 (fi) 1994-09-07
NO943336D0 (no) 1994-09-09
ES2144501T3 (es) 2000-06-16
PT643045E (pt) 2000-08-31

Similar Documents

Publication Publication Date Title
DE69225970D1 (de) Substituierte 2-phenyl-3-methocypropensäurenester als fungizide mittel.
ATE84413T1 (de) Arzneimittel, enthaltend di-tert.butylhydroxyphenyl-derivatesowie neue derivate.
AU2337097A (en) Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
CA2017376A1 (en) Diarylstyrylquinoline diacids
EP0532705A4 (en) Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene d 4?
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
FI955118A0 (fi) Herbisidiset substituoidut 1-fenyyli- tai 1-pyridinyyli-bentsotriatsolit
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
AU649499B2 (en) Fluorine compounds
TR26619A (tr) YENI BILESIKLER,BUNLARIN HAZIRLANMALARINA YÖNELIK ISLEMLER,BUNLARI ICEREN BILESIMLER VE BUNLARIN ZARARLI OT ÖLDüRüCüSü(HERBISIDAL) OLARAK KULLANI- MI.
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
AU644474B2 (en) Heteroarylmethylbenzenes
ATE190307T1 (de) Chinolin-verbindungen als leukotriene antagonisten
AU3196293A (en) Heteroaryl substituted biphenylmethyl benzimidazoles
ES2191014T3 (es) Compuestos farmaceuticos de piridina.
ATE165089T1 (de) Thiocarbamoylverbindungen als mikrobizide
SE9401596D0 (sv) New compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition